Evaluation of drug tolerability as a function of toxicity and quality of life in patients enrolled on I-SPY2. The pre-operative window of endocrine therapy to inform radiation therapy decisions (POWER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback